Epitome Biopharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2009.
2009 Delhi, Delhi, India Converted to LLP
Last Updated:
Access Report
About Epitome Biopharmaceuticals Private Limited

Epitome Biopharmaceuticals Private Limited, a converted to llp private limited company, was established on 20 April 2009 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74900DL2009PTC189519. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.10 M.

Past directors included Nitin Kansal, Sanjeev Kansal. Its latest AGM occurred on 20 September 2018, with the balance sheet filed on 31 March 2018. It is based at B - 135 Gautam Nagar, Delhi, Delhi, 110049.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900DL2009PTC189519

  • Registration Number

    189519

  • Incorporation Date

    20 April 2009

  • Authorized Capital

    ₹1.20 M

  • Paid-Up Capital

    ₹1.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 1.20 M
  • Paid Up Capital ₹ 1.10 M
  • Company Age 16 Year, 10 Months
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth **** %
  • Profit Growth **** -6828.72%
  • Ebitda **** -6828.72%
  • Net Worth -0.21%
  • Total Assets -0.02%
Company report

Epitome Biopharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Epitome Biopharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Epitome Biopharmaceuticals Private Limited?
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Sep 2018 Past
Pramod Abcsdd Director 26 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Epitome Biopharmaceuticals.

Epitome Biopharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 6828.72% decrease in profit. The company's net worth dipped by a decrease of 0.21%.

Epitome Biopharmaceuticals revenue growth over time
Epitome Biopharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.02%
*******
*******
*******
*******
Profit or Loss
*******
 -6828.72%
*******
*******
*******
*******
Net Worth
*******
 -0.21%
*******
*******
*******
*******
EBITDA
*******
 -6828.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Epitome Biopharmaceuticals?

In 2018, Epitome Biopharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Epitome Biopharmaceuticals?

Unlock and access historical data on people associated with Epitome Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Epitome Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epitome Biopharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Epitome Biopharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Epitome Biopharmaceuticals Private Limited last Annual general meeting of members was held on 20 Sep 2018 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Epitome Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was documented.

  • Company Incorporation

    The activity Epitome Biopharmaceuticals Private Limited was registered on 20 Apr 2009 with Roc Delhi & aged 16 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Epitome Biopharmaceuticals Private Limited?

The CIN of Epitome Biopharmaceuticals Private Limited is U74900DL2009PTC189519.

Where is Epitome Biopharmaceuticals Private Limited headquartered?

Epitome Biopharmaceuticals Private Limited is headquartered at B - 135 Gautam Nagar, Delhi, Delhi, 110049.

When was Epitome Biopharmaceuticals Private Limited incorporated?

Epitome Biopharmaceuticals Private Limited was incorporated on 20 April 2009.

What is the primary industry of Epitome Biopharmaceuticals Private Limited?

The primary industry of Epitome Biopharmaceuticals Private Limited is Pharma.

Is Epitome Biopharmaceuticals Private Limited a listed company?

Epitome Biopharmaceuticals Private Limited is unlisted.

What is the capital structure of Epitome Biopharmaceuticals Private Limited?

The authorized capital of Epitome Biopharmaceuticals Private Limited is ₹1.20 M, and the paid-up capital is ₹1.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available